Surgical management of truncal soft tissue sarcoma and other selected soft tissue neoplasms.

Chin Clin Oncol

Oncology Service Line, The Queen's Medical Center, Honolulu, HI, USA; Department of Surgery, John A. Burns School of Medicine, Honolulu, HI, USA; Clinical and Translational Sciences Program, University of Hawaii Cancer Center, Honolulu, HI, USA.

Published: August 2018

Soft tissue sarcoma (STS) is a heterogeneous entity comprising only 1% of all adult cancers that has received considerable attention since it was initially described after the 1st century as "fleshy" by Claudius Galenus. Nick-named the forgotten cancer, more than 100 histologic subtypes have been identified making treatment paradigms extremely complex. A key principle in the management of truncal STS is a defined multi-disciplinary team consisting of several providers. In most instances, surgery is the cornerstone of treatment. This overview will focus on the management of truncal sarcoma from a surgical perspective that will entail several points of consideration including histologic subtype, degree of differentiation, margin status as well as necessity of reconstruction; it will also include discussion of other unique soft tissue neoplasms relevant to the breast and abdominal wall.

Download full-text PDF

Source
http://dx.doi.org/10.21037/cco.2018.08.07DOI Listing

Publication Analysis

Top Keywords

soft tissue
16
management truncal
12
tissue sarcoma
8
tissue neoplasms
8
surgical management
4
soft
4
truncal soft
4
tissue
4
sarcoma selected
4
selected soft
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!